Multiple sclerosis
Lupus
Crohn’s disease
Arthritis
Scleroderma
Myasthenia Gravis

Autoimmune disease refers to a group of conditions present in patients who develop an overactive immune response against their own tissues, and/or against substances that are normally present in the body.

In some cases, specific auto-antibodies have been identified that can be measured in the blood and shown to be responsible for the destruction of the normal cells, such as the antibodie anti-myelin in multiple sclerosis (the rheumatoid factor in rheumatoid arthritis). In other conditions, the destruction of the cells is directly operated by abnormal cells of the immune system.

At present, clinical trials using peripheral blood stem cells are being conducted worldwide for patients diagnosed with lupus, scleroderma, multiple sclerosis, autoimmune arthritis, Crohn’s disease, primary biliary cirrhosis and other autoimmune diseases.

High doses of drugs are used to suppress the immune system. They are usually given prior to undergoing cell therapy through apheresis and the reintroduction of peripheral blood stem cells into the blood.

Recently, results have  shown  that these treatments seem to induce sustained remission of the disease in a majority of patients, even if they were not responsive to conventional treatments.

For some conditions, a combination of both peripheral blood stem cells and umbilical cord blood stem cells might be preferred as they increase the efficacy of the treatment to “reset” the immune system to a more normal level.

Cell therapy is combined with a comprehensive holistic approach. The entire treatment takes five days to complete and includes lifestyle and diet recommendations, personalized natural supplements, a prescription for neuron support, and light physical therapy.

Patients are followed up at regular intervals, post stem cell therapy to monitor their progress.